Jeffrey Epstein funded research at John Hopkins University to combat colon cancer resistance to inhibitor drugs. The research, led by Martin Nowak, revealed the need for a cocktail approach to combat cancer mutations. Dr. Bert Vogelstein and Nowak's team found that cancer cells develop resistance to inhibitor drugs, necessitating a combination of drugs to target all mutations.
documents/EFTA01149566.pdf
{}